InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: SPORT19 post# 128036

Monday, 06/07/2021 1:55:00 PM

Monday, June 07, 2021 1:55:00 PM

Post# of 140474
If they don't need two platforms to market, then how do you explain the success of ISRG while marketing more than one system at a time? They had to start somewhere, but once they got a second system ready, they have always done much better than when they had only one platform. And if it wasn't worth the effort of supporting a second system, they wouldn't still do it. They would have tried it and called it a failed experiment. So a second robotic surgery offering is CLEARLY beneficial to anyone in this market space. Do they NEED two systems? Not to make their initial in-roads in the market. Do they NEED two systems to be competitive with ISRG? Maybe, maybe not... but has history shown that having a second product offering is beneficial? Unquestionably yes.



Message in reply to:
I’m not the one making claims…all in my opinion…

In my opinion Medtronic doesn’t want the enos platform. The Medtronic development deal and the development of enos is separate. Medtronic hasn’t purchased a single share of this company. They paid next to nothing for 1/3 of the IP…
Will there be more development deals with Medtronic? Maybe.
I just don’t think they want enos and aren’t gonna pay billions for something they don’t want. They have a platform that will soon be approved. They don’t need 2 platforms to market.